Bristol-Myers Squibb to Take Part in Goldman Sachs Healthcare CEOs Unscripted Conference

NEW YORK--()--Bristol-Myers Squibb Company (NYSE:BMY) announced today that it will take part in Goldman Sachs Healthcare CEOs Unscripted Conference on Tuesday, January 7, 2014, in Boston. Lamberto Andreotti, chief executive officer, will answer questions about the company at 10:15 a.m. EST.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Contacts

Bristol-Myers Squibb Company
Media:
Laura Hortas, 609-252-4587
laura.hortas@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com
or
Ranya Dajani, 609-252-5330
Ranya.dajani@bms.com
or
Ryan Asay, 609-252-5020
ryan.asay@bms.com

Release Summary

Bristol-Myers Squibb to Take Part in Goldman Sachs Healthcare CEOs Unscripted Conference

Sharing

Contacts

Bristol-Myers Squibb Company
Media:
Laura Hortas, 609-252-4587
laura.hortas@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com
or
Ranya Dajani, 609-252-5330
Ranya.dajani@bms.com
or
Ryan Asay, 609-252-5020
ryan.asay@bms.com